Cranioplasty using cadaveric bone graft for “Growing skull fracture” and Ten- year follow up
Journal Title: The Indian Practitioner - Year 2016, Vol 69, Issue 11
Abstract
Growing skull fracture (GSF), a delayed cranio-cerebral complication resulting from linear skull fracture with dural tear. Damaging effects on the developing skull and brain are significant. Dur-al tear results in leptomeningeal cyst formationwhich if left untreated progressively induces local resorption of skull bone resulting in GSF. It damages the progressively-developing brain. Various materials are available for cranioplasty. It is directed at protecting dura and brain. Ca-daveric bone is the most biological, physiologically suitable material available.It may have im-mediate effect on stopping skull-bone resorption. In our knowledge this is the one of the initial cases of reconstructive-cranioplasty using cadaveric skull bone in GSF. Its effects followed up with 10-years clinical & radiological studies. It is used with the intention of studying 1) host’s ability to regenerate skull bone after cadaveric bone grafting and 2) short term & long term effects of bone grafting in paediatric age group
Authors and Affiliations
Ramesh Sangle, Varun V Nivargi
Keywords
Related Articles
- EP ID EP578385
- DOI -
- Views 66
- Downloads 0
Renal Carcinoid Tumour
Carcinoid tumours are low grade malignant neuroendocrine tumours found mainly in small intestine, lungs.1 However primary carcinoid tumour is not normally present in the kidneys, this being an extremely rare renal malign...
Maternal risk factors of gestational diabetes mellitus A case control study in a tertiary care setting of Delhi
Background: Gestational diabetes mellitus (GDM) has been observed to be associated with increased perinatal morbidity and mortality. GDM is becoming a public health concern globally as well as in India with fast increasi...
Recurrent Pregnancy Loss Is Immunotherapy Effective?
Recurrent pregnancy loss (RPL) is defined as 3 or more consecutive losses of pregnancy. It is a distressing problem for the patient, her family and even the obstetrician and therefore, it is not uncommon to start the dia...
Teneligliptin – The Newest DPP4 Inhibitor
Teneligliptin is the newest DPP4 inhibitor approved by the regulatory authority for the treatment of Diabetes mellitus. Teneligliptin scores over other ‘gliptins’ in being more economical and with better efficacy to cont...
Pharmacovigilance - A Global System of Monitoring ADRs
No drug is safe. Every drug has the potential to develop minor to life threatening adverse effects. Adverse Drug Reactions (ADRs) are one of the major causes of morbidity & mortality worldwide. It adds economic burden to...